Status:
COMPLETED
Novel Biomarkers in Inflammatory Bowel Disease
Lead Sponsor:
Assiut University
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18-70 years
Brief Summary
The inflammatory bowel diseases represent a heterogeneous group of chronic , relapsing- inflammatory disorders of the gastrointestinal tract. Crohn's disease and ulcerative colitis are the two major c...
Detailed Description
The inflammatory bowel diseases represent a heterogeneous group of chronic , relapsing-remitting inflammatory disorders of the gastrointestinal tract, and Crohn's disease and ulcerative colitis are am...
Eligibility Criteria
Inclusion
- Newly diagnosed patients (untreated) by clinical and endoscopic examination and not received treatment .
Exclusion
- patients have autoimmune diseases
- patients with cancer
Key Trial Info
Start Date :
November 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 15 2021
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03833310
Start Date
November 1 2019
End Date
April 15 2021
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuit Medical University
Asyut, Egypt